Azithromycin
Restricted
C difficile risk
Medium
Oral Bioavailability
Good (70 to 90%)
Cost
$3/day
General Information
Pediatrics: Community-acquired PNA (CAP) with concern for atypical pathogens in children ≥5 years old, CAP in sickle cell patients of any age, or I.D. authorization